Immunolocalization of notch signaling protein molecules in a maxillary chondrosarcoma and its recurrent tumor

European Journal of Medical Research

Volumn 15, Issue 10, 2010, Pages 456-460

  Siar, C H ^a   Ha, K O ^a   Aung, L O ^a   Nakano, K ^b   Tsujigiwa, H ^c   Nagatsuka, H ^c   Ng, K H ^d   Kawakami, Toshiyuki ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b MATSUMOTO DENTAL UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Chondrosarcoma; Immunohistochemistry; Notch ligands; Notch receptors

Indexed keywords

JAGGED1; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; PROTEIN; PROTEIN DELTA1; PROTEIN JAGGED2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RECURRENCE; CARTILAGE; CARTILAGE CELL; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CHONDROGENESIS; CHONDROSARCOMA; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOLOCALIZATION; MAXILLA CANCER; PLEOMORPHIC CELL; PRIMARY TUMOR; SIGNAL TRANSDUCTION; SPINDLE CELL;

EID: 78349273097     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-15-10-456     Document Type: Article

References (21)

1. Fletcher CDM, Unni K, Mertens K. Pathology and genetics of tumours of soft tissue and bone. World Health Organization, Geneva, 2002
2. Koch BB, Karnell LH, Hoffman HT, Apostolakis LW, Robinson RA, Zhen W, Menck HR. National cancer database report on chondrosarcoma of the head and neck. Head Neck 2000; 22: 408-425.
3. Prado FO, Nishimoto IN, da Cruz Perez DE, Kowalski LP, Lopes MA. Head and neck chondrosarcoma: Analysis of 16 cases. Br J Oral Maxillofac Surg 2009; 47: 555-557.
4. Mohammadinezhad C. Chondrosarcoma of the jaw. J Craniofac Surg 2009; 20: 2097-2100.
5. van Damme PA, de Wilde PC, Koot RA, Bruaset I, Slootweg PJ, Ruiter DJ. Juxtacortical chondrosarcoma of the mandible: report of a unique case and review of the literature. Int J Oral Maxillofac Surg 2005; 34: 94-98.
6. Saini R, Abd Razak NO, Ab Rahman S, et al. Chondrosarcoma of the mandible: a case report. J Can Dent Assoc 2007; 73:175-178.
7. Shirato T, Onizava K, Yamagata K, Yusa H, Iljima T, Yoshida H. Chondrosarcoma of the mandibular symphysis. Oral Oncol 2006; 43: 247-250.
8. Miele L. Notch signaling. Clin Cancer Res 2006; 12:1074-1079.
9. Fiúza UM, Arias AM. Cell and molecular biology of Notch. J Endocrinol 2007; 194: 459-474.
10. Fortini ME. Notch Signaling: The core pathway and its posttranslational regulation. Dev Cell 2009; 16: 633-647.
11. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284: 770-776.
12. Harper JA, Yuan JS, Tan JB, Visan I, Guidos CJ. Notch signaling in development and disease. Clin Genet 2003; 64: 461-472.
13. Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006; 107: 2223-2233.
14. Nakano K, Nagatsuka H, Tsujigiwa H, Gunduz M, Katase N, Siar CH, Kawakami T. Immunohistochemical characteristics of odontogenic neoplasms and their physiological counterparts. J Hard Tissue Biol 2008: 79-90.
15. Ijuin k, Nakanishi K, Ito K. Different downstream pathways for Notch signaling are required for gliogenic and chondrogenic specification of mouse mesencephalic neural crest cells. Mech Dev 2008; 125: 462-474.
16. Oldershaw RA, Hardingham TE. Notch signaling during chondrogenesis of human bone marrow stem cells. Bone 2010; 46: 286-293.
17. Kawakami T, Siar CH, Ng KH, Shimizu T, Okafuji N, Kurihara S, Tsujigiwa H, Nagatsuka H, Nagai N. Expression of Notch in a case of osteosarcoma of the maxilla. Eur J Med Res 2004; 9: 1-3.
18. Kawakami T, Shimizu T, Kimura A, Hasegawa H, Siar CH, Ng KH, Nagatsuka H, Nagai N, Kanda H. Immunohistochemical examination of cytological differentiation in osteosarcomas. Eur J Med Res 2005; 10: 475-479.
19. Siar CH, Nakano K, Ng KH, Tomida M, Nagatsuka H, Kawakami T. Squamous odontogenic tumor of the mandible: A case report demonstrating immunoexpression of Notch1, 3, 4, Jagged1 and Delta1. Eur J Med Res 2010; 15: 180-184.
20. Nakano K, Siar CH, Tsujigiwa H, Nagatsuka H, Nagai N, Kawakami T. Notch signaling in benign and malignant ameloblastic neoplasms. Eur J Med Res 2008; 13: 476-480.
21. Masuya M, Katayama N, Hoshino N, Nishikawa H, Sakano S, Araki H, Mitani H, Suzuki H, Miyashita H, Kobayashi K, Nishii K, Minami N, Shiku H. The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors. Int J Hematol 2002; 75: 269-276.